Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-04-23 | Ms. Kristina M. BurowIndependent Director | 89,80k | 820,32k | Derivative Exercise and Retained Stock | 4,75 - 26,78 | 103,24k | 668,20% |
| 2026-04-16 | Mr. Robert Keith WoodsCOO | -10,22k | 506,65k | Verkauf | 49,57 | 48,03k | -17,54% |
| 2026-04-16 | Mr. Vikas SinhaCFO & Treasurer | -10,41k | 516,07k | Verkauf | 49,57 | 47,84k | -17,87% |
| 2026-04-16 | Dr. Akshay Krishnadas VaishnawPresident of R&D, Member of Scientific Advisory Board and Director | -12,25k | 607,09k | Verkauf | 49,57 | 58,52k | -17,30% |
| 2026-04-16 | Mr. David L. HallalCEO & Chairman of the Board | -30,62k | 1,52M | Verkauf | 49,57 | 403,53k | -7,05% |
| 2026-02-23 | Mr. Mo QatananiChief Scientific Officer | -8,48k | 399,35k | Automatic Disposition | 46,94 - 48,48 | 0,00 | -100,00% |
| 2026-02-17 | Mr. Mo QatananiChief Scientific Officer | -7,99k | 371,71k | Verkauf | 46,53 | 8,48k | -48,50% |
| 2026-02-17 | Ms. Caryn ParlavecchioChief HR Officer | -9,04k | 420,38k | Verkauf | 46,53 | 86,86k | -9,42% |
| 2026-02-17 | Ms. Junlin HoGeneral Counsel & Corporate Secretary | -9,58k | 445,74k | Verkauf | 46,53 | 131,65k | -6,78% |
| 2026-02-17 | Dr. Jing L. MarantzChief Medical Officer | -4,16k | 193,42k | Verkauf | 46,53 | 29,39k | -12,39% |
| 2025-12-11 | Artal Group S.A.Unternehmen | 1,58M | 11,58M | Derivative Exercise and Retained Stock | 7,35 | 10,83M | 17,03% |
| 2026-01-22 | Mr. Mo QatananiChief Scientific Officer | -14,90k | 695,94k | Automatic Disposition | 45,87 - 46,85 | 85,66k | -14,82% |
| 2026-01-16 | Mr. Mo QatananiChief Scientific Officer | -8,41k | 373,88k | Verkauf | 44,48 | 100,56k | -7,71% |
| 2026-01-16 | Dr. Jing L. MarantzChief Medical Officer | -5,80k | 257,88k | Verkauf | 44,48 | 24,97k | -18,84% |
| 2026-01-16 | Ms. Caryn ParlavecchioChief HR Officer | -6,60k | 293,55k | Verkauf | 44,48 | 78,28k | -7,78% |
| 2026-01-16 | Ms. Junlin HoGeneral Counsel & Corporate Secretary | -8,02k | 356,53k | Verkauf | 44,48 | 121,47k | -6,19% |
| 2026-01-14 | Mr. Mo QatananiChief Scientific Officer | -13,11k | 349,65k | Derivative Exercise and Sale | 7,62 - 45,20 | 108,96k | - |
| 2026-01-13 | Mr. Vikas SinhaCFO & Treasurer | -16,76k | 715,44k | Verkauf | 42,70 | 33,25k | -33,51% |
| 2026-01-13 | Mr. Robert Keith WoodsCOO | -16,75k | 715,05k | Verkauf | 42,70 | 33,25k | -33,49% |
| 2026-01-13 | Dr. Akshay Krishnadas VaishnawPresident of R&D, Member of Scientific Advisory Board and Director | -20,44k | 872,70k | Verkauf | 42,70 | 45,77k | -30,87% |
| 2026-01-13 | Mr. David L. HallalCEO & Chairman of the Board | -57,45k | 2,45M | Verkauf | 42,70 | 371,65k | -13,39% |
| 2025-12-16 | Ms. Katie PengIndependent Director | -1,01k | 44,35k | Automatic Disposition | 43,88 - 44,63 | 14,84k | -6,35% |
| 2025-10-07 | Samsara BioCapital LLCUnternehmen | 4,40k | 180,39k | Kauf | 40,97 | 6,37M | 0,07% |
| 2025-10-07 | Samsara BioCapital LLCUnternehmen | 25,20k | 1,00M | Kauf | 39,31 - 40,18 | 6,37M | 0,40% |
| 2025-12-12 | Samsara BioCapital LLCUnternehmen | 1,06M | 7,83M | Derivative Exercise and Retained Stock | 7,35 | 6,37M | 20,08% |
| 2025-12-04 | Mr. Mo QatananiChief Scientific Officer | -136,46k | 3,28M | Derivative Exercise and Sale | 4,86 - 45,21 | 108,96k | - |
| 2025-10-08 | Mr. David L. HallalCEO & Chairman of the Board | -205,00k | 0,00 | Other Disposition | - | 304,10k | -40,27% |
| 2025-10-03 | Samsara BioCapital LLCUnternehmen | 500,44k | 18,81M | Kauf | 35,61 - 39,52 | 5,30M | 10,42% |
| 2025-09-22 | Mr. Mo QatananiChief Scientific Officer | -3,35k | 102,85k | Automatic Disposition | 30,67 | 108,96k | -2,99% |
| 2025-09-16 | Mr. Mo QatananiChief Scientific Officer | -3,18k | 106,53k | Verkauf | 33,52 | 112,32k | -2,75% |
| 2025-09-16 | Ms. Katie PengIndependent Director | -1,01k | 32,73k | Automatic Disposition | 32,48 - 33,20 | 13,69k | -6,85% |
| 2025-08-18 | Ms. Caryn ParlavecchioChief HR Officer | -2,18k | 67,88k | Verkauf | 31,17 | 66,22k | -3,18% |
| 2025-07-16 | Dr. Jeffrey S. FlierIndependent Director & Member of Scientific Advisory Board | -11,14k | 445,69k | Automatic Disposition | 40,02 | 16,44k | -40,39% |
| 2025-07-08 | Mr. Mo QatananiChief Scientific Officer | -24,07k | 828,90k | Automatic Disposition | 34,44 | 0,00 | -100,00% |
| 2025-06-23 | Dr. Jeffrey S. FlierIndependent Director & Member of Scientific Advisory Board | -20,32k | 215,67k | Derivative Exercise and Sale | 21,62 - 32,74 | 27,57k | - |
| 2025-06-23 | Dr. Jeffrey S. FlierIndependent Director & Member of Scientific Advisory Board | -11,14k | 369,82k | Automatic Disposition | 33,21 | 27,57k | -28,77% |
| 2025-06-16 | Ms. Junlin HoGeneral Counsel & Corporate Secretary | -7,44k | 238,15k | Verkauf | 32,00 | 105,65k | -6,58% |
| 2025-06-16 | Ms. Katie PengIndependent Director | -3,03k | 96,89k | Automatic Disposition | 31,96 - 32,53 | 12,39k | -19,66% |
| 2025-06-16 | Mr. Mo QatananiChief Scientific Officer | -3,67k | 117,38k | Verkauf | 32,00 | 24,07k | -13,23% |
| 2025-06-16 | Ms. Caryn ParlavecchioChief HR Officer | -6,19k | 197,96k | Verkauf | 32,00 | 64,20k | -8,79% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
